Business
Sellas Life Sciences Stock Triples After Cancer Vaccine Data
Avalon Pernell·Bloomberg·November 17, 2026
Sellas Life Sciences Group Inc. surged after the drug developer reported positive late-stage trial results for an experimental cancer vaccine to treat an aggressive form of blood cancer.
Read the full story at Bloomberg →